CP
Crinetics Pharmaceuticals Inc
🇺🇸XNAS.CRNXUnited StatesHealthcare
$84.95USDunchanged 0.00 (0%)OpenDelayed5:17 PM
Price$84.950.00 (0%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US22663K1079
- CUSIP
- 22663K107
Company
- Employees
- 594
- Headquarters
- San Diego, United States
- Website
- https://www.crinetics.com
- CEO
- Dr. R. Scott Struthers Ph.D.
Market
- Shares outstanding
- 106.1M
- Market cap
- $9.01B
Highlights
No high and low reported for today's session.
- Market cap
- $9.01B
- EPS LTM
- -$4.75
- P/E LTM
- -7.87
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $42.16M+2,928.45%up year on year
- Net income
- -$501.61M-35.63%down year on year
- Gross margin
- -114.34%+98.76%up year on year
- Free cash flow
- -$425.18M-39.05%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.